Startups

Bexson Biomedical

Bexson Biomedical develops subcutaneous drug formulations and delivery systems, including ketamine-based treatments for pain and mental health conditions.

Team

Ahmed RagabCEO

Bryon WornsonCOO

Jason WallachHead of Medicinal Chemistry

Jeffrey BeckerCo-founder and CSO

Mick HurreyChief Development Officer

Rosemary GonzalesSVP Quality and Regulatory

Sheldon MobergCTO

Investments

$—Unknown date

PsyMed Ventures